Abstract:A novel protein scaffold based on the cystine knot domain of the agouti-related protein (AgRP) has been used to engineer mutants that can bind to the α v β 3 integrin receptor with high affinity and specificity. In the current study, an 18 F-labeled AgRP mutant (7C) was prepared and evaluated as a positron emission tomography (PET) probe for imaging tumor angiogenesis. AgRP-7C was synthesized by solid phase peptide synthesis and site-specifically conjugated with 4-nitrophenyl 2- 18/19 F-fluoropropionate ( 18/19 F-NFP) to produce the fluorinated peptide, 18/19 F-FP-AgRP-7C. Competition binding assays were used to measure the relative affinities of AgRP-7C and 19 F-FP-AgRP-7C to human glioblastoma U87MG cells that overexpress α v β 3 integrin. In addition, biodistribution, metabolic stability, and small animal PET imaging studies were conducted with 18 F-FP-AgRP-7C using U87MG tumor-bearing mice. Both AgRP-7C and 19 F-FP-AgRP-7C specifically competed with 125 I-echistatin for binding to U87MG cells with half maximal inhibitory concentration (IC 50 ) values of 9.40 and 8.37 nM, respectively. Non-invasive small animal PET imaging revealed that 18 F-FP-AgRP-7C exhibited rapid and good tumor uptake (3.24 percentage injected dose per gram [% ID/g] at 0.5 h post injection [p.i.]). The probe was rapidly cleared from the blood and from most organs, resulting in excellent tumor-to-normal tissue contrasts. Tumor uptake and rapid clearance were further confirmed with biodistribution studies. Furthermore, co-injection of 18 F-FP-AgRP-7C with a large molar excess of blocking peptide c(RGDyK) significantly inhibited tumor uptake in U87MG xenograft models, demonstrating the integrin-targeting specificity of the probe. Metabolite assays showed that the probe had high stability, making it suitable for in vivo applications. 18 F-FP-AgRP-7C exhibits promising in vivo properties such as rapid tumor targeting, good tumor uptake, and excellent tumor-to-normal tissue ratios, and warrants further investigation as a novel PET probe for imaging tumor angiogenesis.

Structural Characterization and Pharmacology of a Potent (Cys101-Cys119, Cys110-Cys117) Bicyclic Agouti-Related Protein (AGRP) Melanocortin Receptor Antagonist.

Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity

Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors

Structures of Human Gastrin-Releasing Peptide Receptors Bound to Antagonist and Agonist for Cancer and Itch Therapy.

The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors

A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

G Protein-Coupled Estrogen Receptor (Gper) Agonist Dual Binding Mode Analyses Toward Understanding Of Its Activation Mechanism: A Comparative Homology Modeling Approach

Novel Cocrystal Structures of Peptide Antagonists Bound to the Human Melanocortin Receptor 4 Unveil Unexplored Grounds for Structure-Based Drug Design

The Parallel Structure–Activity Relationship Screening of Three Compounds Identifies the Common Agonist Pharmacophore of Pyrrolidine Bis-Cyclic Guanidine Melanocortin-3 Receptor (MC3R) Small-Molecule Ligands

Drugs in dentistry. Agents for plaque control.

Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor

Ψ and χ Angle Constrains at the C-Terminus Trp Position of the Melanotropin Tetrapeptide Ac-His-d-Phe-Arg-Trp-NH2 Lead to Potent and Selective Agonists at hMC1R and hMC4R

Probing the Mechanism of Receptor Activity–Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists

Structural Basis for ( S)-3,4-Dicarboxyphenylglycine (DCPG) As a Potent and Subtype Selective Agonist of the mGlu 8 Receptor.

Development of Picomolar Affinity Antagonists and Long‐acting Agonists for the Adrenomedullin and CGRP Receptors Using Combinatorial Peptide Library and Structure‐guided Design Approaches

A Peptide That Antagonizes TCR-Mediated Reactions with Both Syngeneic and Allogeneic Agonists: Functional and Structural Aspects

Krüppel-like factor 4 in transcriptional control of the three unique isoforms of Agouti-related peptide in mice